METHIMAZOLE Drug Patent Profile
✉ Email this page to a colleague
When do Methimazole patents expire, and when can generic versions of Methimazole launch?
Methimazole is a drug marketed by Bionpharma, Chartwell Rx, Discovery Therap, Heritage Pharma, Macleods Pharms Ltd, Mylan, Qingdao Baheal Pharm, Rising, and Sun Pharm Inds Inc. and is included in nine NDAs.
The generic ingredient in METHIMAZOLE is methimazole. There are three drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methimazole
A generic version of METHIMAZOLE was approved as methimazole by MYLAN on March 29th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHIMAZOLE?
- What are the global sales for METHIMAZOLE?
- What is Average Wholesale Price for METHIMAZOLE?
Summary for METHIMAZOLE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 174 |
| Clinical Trials: | 22 |
| Patent Applications: | 2,721 |
| Drug Prices: | Drug price information for METHIMAZOLE |
| Drug Sales Revenues: | Drug sales revenues for METHIMAZOLE |
| DailyMed Link: | METHIMAZOLE at DailyMed |
See drug prices for METHIMAZOLE
Recent Clinical Trials for METHIMAZOLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Case Comprehensive Cancer Center | Phase 2 |
| The First Affiliated Hospital of Xiamen University | Phase 2/Phase 3 |
| Cheloo Hospital (Qingdao), Shandong University | Early Phase 1 |
Pharmacology for METHIMAZOLE
| Drug Class | Thyroid Hormone Synthesis Inhibitor |
| Mechanism of Action | Thyroid Hormone Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for METHIMAZOLE
US Patents and Regulatory Information for METHIMAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | METHIMAZOLE | methimazole | TABLET;ORAL | 218149-001 | Sep 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Inds Inc | METHIMAZOLE | methimazole | TABLET;ORAL | 040870-001 | Sep 25, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Heritage Pharma | METHIMAZOLE | methimazole | TABLET;ORAL | 040734-002 | Dec 14, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | METHIMAZOLE | methimazole | TABLET;ORAL | 040411-002 | Mar 27, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | METHIMAZOLE | methimazole | TABLET;ORAL | 040350-003 | Jun 7, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
